Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anne Fuhlbrigge

Concepts (429)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
98
2025
1800
9.620
 Why?
Anti-Asthmatic Agents
28
2025
263
3.290
 Why?
Adrenal Cortex Hormones
28
2025
483
3.250
 Why?
Forced Expiratory Volume
19
2019
451
1.510
 Why?
Pulmonary Disease, Chronic Obstructive
11
2022
926
1.350
 Why?
Severity of Illness Index
20
2020
2910
0.940
 Why?
Administration, Inhalation
25
2025
567
0.930
 Why?
Anti-Inflammatory Agents
10
2016
473
0.840
 Why?
Albuterol
5
2015
76
0.810
 Why?
Bronchodilator Agents
12
2016
186
0.810
 Why?
Lung Transplantation
10
2017
326
0.780
 Why?
Budesonide
14
2016
49
0.770
 Why?
Remote Consultation
4
2025
67
0.720
 Why?
Nedocromil
11
2016
20
0.690
 Why?
Humans
129
2025
145625
0.670
 Why?
Nasal Polyps
1
2021
59
0.670
 Why?
Self Report
3
2023
869
0.660
 Why?
Endpoint Determination
2
2020
84
0.650
 Why?
Pharmacogenetics
2
2015
176
0.640
 Why?
Food Hypersensitivity
1
2022
165
0.620
 Why?
Sinusitis
1
2021
220
0.580
 Why?
Virus Diseases
1
2021
219
0.560
 Why?
Glucocorticoids
4
2022
536
0.550
 Why?
Lung
7
2019
4119
0.550
 Why?
Physicians
2
2021
954
0.540
 Why?
Symptom Assessment
1
2019
137
0.530
 Why?
Hospitalization
13
2020
2468
0.510
 Why?
Sleep Apnea, Obstructive
1
2021
300
0.510
 Why?
Androstadienes
3
2012
77
0.490
 Why?
Bone Density
2
2014
492
0.480
 Why?
Child
53
2022
22638
0.480
 Why?
Disease Progression
14
2020
2857
0.470
 Why?
Managed Care Programs
8
2008
137
0.470
 Why?
Oxygen Inhalation Therapy
4
2020
189
0.470
 Why?
Male
82
2025
73014
0.450
 Why?
Precision Medicine
1
2020
462
0.450
 Why?
Adult
47
2025
40821
0.440
 Why?
Emergency Service, Hospital
9
2013
2357
0.440
 Why?
Adrenergic beta-2 Receptor Agonists
4
2020
26
0.430
 Why?
Cost Savings
1
2015
85
0.430
 Why?
Female
81
2025
79080
0.420
 Why?
Practice Patterns, Physicians'
7
2020
1370
0.410
 Why?
Patient Reported Outcome Measures
1
2018
502
0.410
 Why?
Peak Expiratory Flow Rate
2
2011
25
0.390
 Why?
Cost-Benefit Analysis
7
2022
632
0.380
 Why?
Phenotype
6
2025
3186
0.370
 Why?
Middle Aged
40
2025
36359
0.370
 Why?
Comorbidity
4
2021
1652
0.350
 Why?
Academic Medical Centers
3
2024
560
0.330
 Why?
Surveys and Questionnaires
14
2022
6050
0.330
 Why?
Adolescent
37
2019
22451
0.320
 Why?
Medical Records Systems, Computerized
3
2008
94
0.320
 Why?
Mentors
1
2012
215
0.320
 Why?
Administration, Oral
6
2021
867
0.320
 Why?
Respiratory Function Tests
10
2015
543
0.310
 Why?
Quality of Life
12
2023
3187
0.310
 Why?
United States
23
2022
16041
0.300
 Why?
Interprofessional Relations
3
2021
274
0.300
 Why?
Faculty, Medical
1
2012
305
0.290
 Why?
Spirometry
8
2020
234
0.290
 Why?
Child, Preschool
31
2016
11888
0.290
 Why?
Child Development
1
2014
481
0.290
 Why?
Treatment Outcome
16
2025
11744
0.290
 Why?
Group Practice
1
2008
6
0.280
 Why?
Anti-Allergic Agents
2
2008
41
0.270
 Why?
Oxygen
3
2018
996
0.270
 Why?
Computer Simulation
1
2012
1014
0.270
 Why?
Aged
22
2022
26251
0.260
 Why?
Dyspnea
3
2022
251
0.250
 Why?
Drug Utilization
4
2005
170
0.240
 Why?
Randomized Controlled Trials as Topic
8
2020
1754
0.240
 Why?
Primary Health Care
5
2025
1768
0.230
 Why?
Primary Graft Dysfunction
2
2017
32
0.230
 Why?
Quality Assurance, Health Care
1
2008
339
0.230
 Why?
Follow-Up Studies
17
2017
5397
0.230
 Why?
Bronchiolitis Obliterans
3
2017
59
0.230
 Why?
Respiratory Sounds
1
2006
102
0.230
 Why?
Gift Giving
1
2005
9
0.220
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.220
 Why?
Allergists
2
2022
13
0.220
 Why?
Genetic Testing
1
2008
491
0.220
 Why?
Delivery of Health Care
2
2021
942
0.220
 Why?
Medication Adherence
2
2023
535
0.200
 Why?
Specialization
2
2025
136
0.200
 Why?
Cohort Studies
14
2013
6045
0.200
 Why?
Natural Language Processing
1
2025
103
0.200
 Why?
Retrospective Studies
18
2024
17291
0.200
 Why?
Time Factors
10
2020
7079
0.200
 Why?
Massachusetts
5
2016
178
0.200
 Why?
Leadership
2
2022
410
0.200
 Why?
Antibodies, Monoclonal
2
2008
1511
0.200
 Why?
Medicine
1
2025
126
0.190
 Why?
Rhinitis, Allergic, Perennial
1
2003
20
0.190
 Why?
Genetic Variation
1
2008
992
0.190
 Why?
Steroids
8
2011
160
0.190
 Why?
Recurrence
5
2013
1125
0.190
 Why?
Health Status
1
2008
822
0.180
 Why?
Genetic Predisposition to Disease
2
2025
2455
0.180
 Why?
Predictive Value of Tests
9
2012
2097
0.180
 Why?
Beclomethasone
1
2022
8
0.180
 Why?
Models, Theoretical
4
2007
558
0.180
 Why?
Multicenter Studies as Topic
4
2018
413
0.180
 Why?
Young Adult
11
2019
14240
0.180
 Why?
Prevalence
4
2022
2852
0.170
 Why?
Tiotropium Bromide
2
2018
5
0.170
 Why?
Desensitization, Immunologic
1
2022
91
0.170
 Why?
Nebulizers and Vaporizers
2
2020
63
0.170
 Why?
Biomarkers
3
2021
4329
0.170
 Why?
Social Class
2
2022
260
0.160
 Why?
Patient Preference
1
2023
224
0.160
 Why?
Churg-Strauss Syndrome
1
2020
27
0.160
 Why?
Bronchoconstriction
3
2011
29
0.160
 Why?
Pulmonologists
1
2020
14
0.160
 Why?
Granulomatosis with Polyangiitis
1
2020
48
0.160
 Why?
Capacity Building
1
2021
61
0.160
 Why?
Muscarinic Antagonists
1
2020
30
0.160
 Why?
Agammaglobulinemia
1
2020
36
0.150
 Why?
Physician-Patient Relations
2
2021
595
0.150
 Why?
Air Pollution, Indoor
2
2002
169
0.150
 Why?
Practice Guidelines as Topic
5
2020
1581
0.150
 Why?
Electronic Health Records
2
2025
1208
0.150
 Why?
Risk Factors
12
2018
10840
0.150
 Why?
Treatment Adherence and Compliance
1
2019
27
0.140
 Why?
Exercise Test
1
2022
634
0.140
 Why?
Receptors, IgE
2
2009
43
0.140
 Why?
Allergens
1
2021
390
0.130
 Why?
Prognosis
8
2017
4331
0.130
 Why?
Vitamin D
2
2012
402
0.130
 Why?
Fossil Fuels
1
1997
8
0.130
 Why?
Hypersensitivity
1
2020
253
0.130
 Why?
Alemtuzumab
1
2017
15
0.130
 Why?
Photopheresis
1
2017
9
0.130
 Why?
Drug Prescriptions
2
2011
290
0.130
 Why?
Biological Products
1
2020
257
0.120
 Why?
Respiration
1
2017
207
0.120
 Why?
Physicians, Primary Care
3
2021
209
0.120
 Why?
Respiration Disorders
1
1997
78
0.120
 Why?
Emergency Medical Services
2
2007
680
0.120
 Why?
Statistics, Nonparametric
1
2017
423
0.120
 Why?
Drug Therapy, Combination
5
2020
1034
0.120
 Why?
Drug Combinations
3
2012
399
0.120
 Why?
Immunomodulation
1
2017
98
0.120
 Why?
Drug Monitoring
1
2020
399
0.120
 Why?
Socioeconomic Factors
4
2022
1323
0.120
 Why?
Tobacco Smoke Pollution
2
2010
227
0.120
 Why?
Scopolamine Derivatives
1
2015
3
0.120
 Why?
Breath Tests
2
2008
77
0.120
 Why?
Immunoglobulin G
1
2020
899
0.110
 Why?
Embolism, Fat
1
2015
11
0.110
 Why?
Aged, 80 and over
6
2019
8351
0.110
 Why?
Patient Admission
1
2018
216
0.110
 Why?
Cholinergic Antagonists
1
2015
24
0.110
 Why?
Transplants
1
2015
36
0.110
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2015
103
0.110
 Why?
Fluticasone-Salmeterol Drug Combination
2
2012
7
0.110
 Why?
Carcinoma, Bronchogenic
1
2015
20
0.110
 Why?
Genomics
2
2018
851
0.110
 Why?
Longitudinal Studies
6
2017
3005
0.100
 Why?
Graft Rejection
2
2013
504
0.100
 Why?
Overweight
2
2011
613
0.100
 Why?
Respiratory Tract Infections
2
2012
399
0.100
 Why?
Referral and Consultation
1
2021
878
0.100
 Why?
Ambulatory Care Information Systems
2
2005
5
0.100
 Why?
Prednisolone
1
2014
65
0.100
 Why?
Telemedicine
1
2023
956
0.100
 Why?
Risk
4
2015
917
0.100
 Why?
Postoperative Complications
2
2017
2962
0.100
 Why?
Guideline Adherence
3
2020
585
0.100
 Why?
Education, Medical, Continuing
2
2005
130
0.100
 Why?
Airway Obstruction
1
2015
152
0.100
 Why?
Environmental Exposure
3
2006
578
0.100
 Why?
Forecasting
1
2015
386
0.100
 Why?
Bronchial Hyperreactivity
3
2010
104
0.100
 Why?
Transplantation
1
2013
31
0.100
 Why?
Office Visits
4
2011
93
0.090
 Why?
Quality Improvement
1
2022
1325
0.090
 Why?
Insurance Claim Review
1
2013
85
0.090
 Why?
Growth
1
2012
48
0.090
 Why?
Peer Group
2
2012
250
0.090
 Why?
Research
1
2015
421
0.090
 Why?
Costs and Cost Analysis
1
2013
216
0.090
 Why?
Double-Blind Method
5
2010
2064
0.090
 Why?
Methacholine Chloride
3
2008
50
0.090
 Why?
Medicare
2
2022
907
0.090
 Why?
Metered Dose Inhalers
1
2012
8
0.090
 Why?
Cytomegalovirus Infections
2
2012
203
0.090
 Why?
Cost of Illness
3
2003
322
0.090
 Why?
Feedback
1
2012
180
0.090
 Why?
Drug Dosage Calculations
1
2011
27
0.090
 Why?
Logistic Models
5
2017
2112
0.090
 Why?
Mycoses
1
2012
86
0.090
 Why?
Antibodies, Monoclonal, Humanized
2
2008
992
0.090
 Why?
Antifungal Agents
1
2012
153
0.090
 Why?
Effect Modifier, Epidemiologic
1
2011
9
0.080
 Why?
Multivariate Analysis
7
2017
1531
0.080
 Why?
Body Height
1
2012
202
0.080
 Why?
Medication Errors
1
2012
86
0.080
 Why?
Morbidity
2
2022
317
0.080
 Why?
Professional Role
1
2012
171
0.080
 Why?
Mycobacterium
1
2012
101
0.080
 Why?
Pneumococcal Vaccines
1
2012
130
0.080
 Why?
Epidemiologic Studies
1
2011
70
0.080
 Why?
Program Development
1
2012
365
0.080
 Why?
Obesity
3
2015
3123
0.080
 Why?
Patient Readmission
1
2016
771
0.080
 Why?
Secondary Prevention
1
2012
247
0.080
 Why?
Drug Resistance
1
2011
145
0.080
 Why?
Diagnostic Errors
1
2012
178
0.080
 Why?
Probability
1
2011
308
0.080
 Why?
Vitamin D Deficiency
1
2012
188
0.080
 Why?
Chi-Square Distribution
2
2017
511
0.080
 Why?
Lung Diseases
1
2017
787
0.080
 Why?
Bronchial Provocation Tests
2
2008
46
0.080
 Why?
Fluticasone
2
2008
53
0.080
 Why?
Pragmatic Clinical Trials as Topic
2
2020
135
0.080
 Why?
Incidence
5
2020
2910
0.070
 Why?
Immunoglobulin E
2
2008
315
0.070
 Why?
Vital Capacity
4
2017
293
0.070
 Why?
Receptors, Corticotropin-Releasing Hormone
1
2009
30
0.070
 Why?
Decision Support Techniques
2
2012
473
0.070
 Why?
Lectins, C-Type
1
2009
61
0.070
 Why?
Algorithms
1
2017
1843
0.070
 Why?
Smoking
3
2017
1478
0.070
 Why?
Health Services
2
2007
112
0.070
 Why?
Medication Therapy Management
1
2010
73
0.070
 Why?
Ambulatory Care
2
2011
627
0.070
 Why?
Proportional Hazards Models
1
2012
1318
0.070
 Why?
Odds Ratio
4
2017
1070
0.070
 Why?
Health Knowledge, Attitudes, Practice
2
2012
1403
0.070
 Why?
Pandemics
3
2022
1700
0.070
 Why?
Surgical Wound Infection
1
2012
331
0.070
 Why?
Acute Disease
1
2011
1033
0.070
 Why?
Kaplan-Meier Estimate
3
2016
959
0.070
 Why?
Vitamin K Epoxide Reductases
1
2008
12
0.070
 Why?
Cytochrome P-450 CYP2C9
1
2008
20
0.070
 Why?
Cross-Sectional Studies
6
2010
5875
0.070
 Why?
Eosinophil Cationic Protein
1
2008
9
0.070
 Why?
Mixed Function Oxygenases
1
2008
43
0.070
 Why?
Adrenergic beta-Agonists
1
2008
91
0.070
 Why?
Program Evaluation
1
2012
945
0.070
 Why?
Aryl Hydrocarbon Hydroxylases
1
2008
45
0.070
 Why?
Genetic Techniques
1
2008
64
0.070
 Why?
Quality-Adjusted Life Years
2
2006
119
0.070
 Why?
Insurance, Pharmaceutical Services
1
2008
23
0.070
 Why?
State Health Plans
1
2008
28
0.070
 Why?
Markov Chains
2
2006
128
0.070
 Why?
Smoking Cessation
1
2012
440
0.070
 Why?
Cost Sharing
1
2008
23
0.070
 Why?
Trastuzumab
1
2008
119
0.070
 Why?
Reimbursement Mechanisms
1
2008
78
0.070
 Why?
Antibodies, Anti-Idiotypic
1
2007
50
0.060
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
339
0.060
 Why?
Chronic Disease
3
2017
1824
0.060
 Why?
Omalizumab
1
2007
44
0.060
 Why?
Factor Analysis, Statistical
1
2008
295
0.060
 Why?
Exercise Tolerance
2
2022
288
0.060
 Why?
Health Surveys
2
2006
511
0.060
 Why?
Influenza Vaccines
1
2012
541
0.060
 Why?
Warfarin
1
2008
179
0.060
 Why?
Interviews as Topic
1
2011
926
0.060
 Why?
Antiviral Agents
1
2012
774
0.060
 Why?
Databases, Factual
1
2012
1481
0.060
 Why?
Animals, Domestic
1
2006
17
0.060
 Why?
Tomography, X-Ray Computed
1
2017
2766
0.060
 Why?
Lung Diseases, Interstitial
1
2013
677
0.060
 Why?
Health Services Accessibility
2
2021
1101
0.060
 Why?
Animals
2
2025
38030
0.060
 Why?
Eosinophils
1
2008
319
0.060
 Why?
Physicians, Family
2
2004
179
0.060
 Why?
Health Benefit Plans, Employee
1
2005
24
0.060
 Why?
Biomedical Research
1
2012
724
0.050
 Why?
Models, Biological
1
2012
1758
0.050
 Why?
Database Management Systems
1
2005
50
0.050
 Why?
Hip Fractures
1
2006
88
0.050
 Why?
Health Policy
1
2008
399
0.050
 Why?
Patients
1
2006
183
0.050
 Why?
Insurance Coverage
1
2006
246
0.050
 Why?
Utilization Review
1
2004
37
0.050
 Why?
Patient Education as Topic
3
2005
769
0.050
 Why?
Infant
3
2008
10093
0.050
 Why?
Body Mass Index
3
2015
2446
0.050
 Why?
Gene Expression Profiling
1
2011
1790
0.050
 Why?
Prenatal Exposure Delayed Effects
1
2010
662
0.050
 Why?
Medicaid
1
2008
472
0.050
 Why?
Clinical Competence
1
2012
1261
0.050
 Why?
Mass Screening
1
2012
1300
0.050
 Why?
Nitric Oxide
1
2008
883
0.050
 Why?
Attitude to Health
1
2006
419
0.050
 Why?
Vaccination
1
2012
1444
0.050
 Why?
Sex Factors
3
2016
2101
0.050
 Why?
Anticoagulants
1
2008
743
0.050
 Why?
Case Management
1
2003
66
0.050
 Why?
Choice Behavior
1
2004
179
0.050
 Why?
Puerto Rico
1
2022
64
0.050
 Why?
Clinical Trials as Topic
2
2005
1062
0.050
 Why?
Parents
3
2006
1393
0.040
 Why?
Symptom Flare Up
1
2022
37
0.040
 Why?
Anti-Bacterial Agents
2
2004
1935
0.040
 Why?
Sputum
1
2004
302
0.040
 Why?
Circadian Rhythm
1
2006
514
0.040
 Why?
Academies and Institutes
1
2022
60
0.040
 Why?
Health Services Research
1
2004
389
0.040
 Why?
Lung Neoplasms
1
2015
2674
0.040
 Why?
Minority Groups
1
2003
285
0.040
 Why?
Survival Rate
2
2016
2078
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
74
0.040
 Why?
Electronics
1
2021
65
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2020
116
0.040
 Why?
Sample Size
1
2020
123
0.040
 Why?
Efficiency
1
2021
102
0.040
 Why?
Health Care Reform
1
2021
109
0.040
 Why?
Schools, Medical
1
2021
157
0.040
 Why?
Risk Assessment
3
2020
3678
0.040
 Why?
Patient Compliance
2
2016
587
0.040
 Why?
Patient Selection
2
2020
720
0.040
 Why?
Language
1
2022
313
0.040
 Why?
Stress, Psychological
1
2007
1169
0.040
 Why?
Cluster Analysis
2
2014
494
0.040
 Why?
Time
1
2019
85
0.040
 Why?
Health Education
1
2002
346
0.040
 Why?
Quality of Health Care
1
2003
692
0.030
 Why?
Poland
1
2017
34
0.030
 Why?
Bronchitis, Chronic
1
2017
16
0.030
 Why?
Republic of Korea
1
2017
43
0.030
 Why?
Cooperative Behavior
1
2021
467
0.030
 Why?
Patient-Centered Care
1
2003
551
0.030
 Why?
Sensitivity and Specificity
3
2013
1992
0.030
 Why?
Nitrogen Dioxide
1
1997
45
0.030
 Why?
Geography
1
2018
186
0.030
 Why?
Monitoring, Physiologic
2
2012
278
0.030
 Why?
Aftercare
1
2019
221
0.030
 Why?
Self Concept
1
2019
257
0.030
 Why?
Netherlands
1
2016
84
0.030
 Why?
Long-Term Care
1
2018
116
0.030
 Why?
Antineoplastic Agents
1
2008
2218
0.030
 Why?
Tuberculosis, Pulmonary
1
2017
127
0.030
 Why?
Pediatrics
1
2005
1122
0.030
 Why?
Perception
1
2019
372
0.030
 Why?
Forced Expiratory Flow Rates
1
2015
10
0.030
 Why?
Formoterol Fumarate
1
2015
6
0.030
 Why?
Salmeterol Xinafoate
1
2015
20
0.030
 Why?
Ethanolamines
1
2015
14
0.030
 Why?
Receptors, Adrenergic, beta-2
1
2015
36
0.030
 Why?
Treatment Failure
1
2016
358
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
2018
0.030
 Why?
Education
1
2015
102
0.030
 Why?
Postoperative Period
1
2016
344
0.030
 Why?
Feasibility Studies
1
2020
1125
0.030
 Why?
Polymorphism, Single Nucleotide
2
2016
2228
0.030
 Why?
Self Efficacy
1
2019
417
0.030
 Why?
Immunosuppressive Agents
2
2015
824
0.030
 Why?
Age Factors
3
2008
3321
0.030
 Why?
Fatal Outcome
1
2015
302
0.030
 Why?
Biopsy
2
2013
1073
0.030
 Why?
Pilot Projects
1
2020
1878
0.030
 Why?
Combined Modality Therapy
1
2017
1269
0.030
 Why?
Patient Acceptance of Health Care
1
2021
880
0.020
 Why?
Gene Expression
1
2018
1461
0.020
 Why?
Telephone
2
2005
175
0.020
 Why?
Echinocandins
1
2012
8
0.020
 Why?
Lipopeptides
1
2012
17
0.020
 Why?
Aspergillosis
1
2012
24
0.020
 Why?
Amphotericin B
1
2012
36
0.020
 Why?
Intention to Treat Analysis
1
2012
78
0.020
 Why?
Tissue Donors
1
2015
398
0.020
 Why?
Candidiasis
1
2012
64
0.020
 Why?
Transplantation, Homologous
1
2013
415
0.020
 Why?
Mycobacterium avium Complex
1
2012
87
0.020
 Why?
Age Distribution
2
2003
395
0.020
 Why?
Cromolyn Sodium
2
2001
6
0.020
 Why?
Leukotriene Antagonists
1
2011
24
0.020
 Why?
Hypoxia
1
2019
1209
0.020
 Why?
Extracorporeal Membrane Oxygenation
1
2015
369
0.020
 Why?
Triazoles
1
2012
190
0.020
 Why?
Self Care
2
2005
396
0.020
 Why?
Functional Residual Capacity
1
2010
7
0.020
 Why?
Reference Values
1
2012
787
0.020
 Why?
Colorado
1
2021
4588
0.020
 Why?
Costa Rica
1
2010
18
0.020
 Why?
Nontuberculous Mycobacteria
1
2012
189
0.020
 Why?
Principal Component Analysis
1
2011
192
0.020
 Why?
Health
1
2010
81
0.020
 Why?
Inhalation
1
2010
28
0.020
 Why?
Genome-Wide Association Study
1
2016
1526
0.020
 Why?
Environment
1
2011
295
0.020
 Why?
Observation
1
2008
51
0.020
 Why?
Sex Ratio
1
2008
17
0.020
 Why?
Least-Squares Analysis
1
2008
73
0.020
 Why?
Models, Econometric
1
2008
35
0.020
 Why?
Prospective Studies
2
2012
8087
0.020
 Why?
Health Services Administration
1
2007
9
0.020
 Why?
Treatment Refusal
1
2008
98
0.020
 Why?
Intelligence
1
2007
118
0.020
 Why?
Social Isolation
1
2007
73
0.020
 Why?
Puberty
1
2008
141
0.020
 Why?
Body Weight
1
2011
964
0.020
 Why?
Child Behavior Disorders
1
2007
117
0.010
 Why?
Exercise
1
2016
2206
0.010
 Why?
CD4-Positive T-Lymphocytes
1
2011
1148
0.010
 Why?
Genotype
1
2009
1866
0.010
 Why?
Insurance, Health
1
2007
315
0.010
 Why?
Bronchoconstrictor Agents
1
2003
14
0.010
 Why?
Organizational Innovation
1
2004
123
0.010
 Why?
Health Status Indicators
1
2004
166
0.010
 Why?
Case-Control Studies
1
2010
3633
0.010
 Why?
Systems Integration
1
2003
36
0.010
 Why?
Motor Activity
1
2007
701
0.010
 Why?
Computer Systems
1
2003
54
0.010
 Why?
Histamine H1 Antagonists
1
2002
24
0.010
 Why?
Drug Administration Schedule
1
2004
782
0.010
 Why?
Self Disclosure
1
2002
62
0.010
 Why?
Child Welfare
1
2004
228
0.010
 Why?
Administration, Intranasal
1
2002
94
0.010
 Why?
Confidence Intervals
1
2002
328
0.010
 Why?
Regression Analysis
1
2003
994
0.010
 Why?
Nurse's Role
1
2003
148
0.010
 Why?
Point-of-Care Systems
1
2003
185
0.010
 Why?
Health Care Surveys
1
2002
538
0.010
 Why?
Sex Distribution
1
2001
379
0.010
 Why?
Patient Satisfaction
1
2004
698
0.010
 Why?
Linear Models
1
2002
847
0.010
 Why?
Disease Management
1
2003
649
0.010
 Why?
Bronchoscopy
1
2000
227
0.010
 Why?
Decision Support Systems, Clinical
1
2003
277
0.010
 Why?
Internet
1
2003
656
0.010
 Why?
Caregivers
1
2007
1079
0.010
 Why?
Pregnancy
1
2010
7217
0.010
 Why?
Survival Analysis
1
2000
1372
0.010
 Why?
Infant, Newborn
1
2004
6449
0.010
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (429) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)